International Study to Predict Optimized Treatment - in Depression
International Study to Predict Optimized Treatment response to the three most commonly used antidepressants (Escitalopram, Sertraline and Venlafaxine extended release XR,) in subjects diagnosed with major depressive disorder (MDD) as compared to matched healthy controls.
Brain Resource
2,688 participants
Jul 15, 2008
Interventional
Conditions
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Once randomised and on drug, subjects will be dosed with study medication as per local/country standard of care. Therefore, the length of treatment will differ and is based on the subjects response. escitalopram one 10 mg tablet orally once daily (QD) sertraline one 50 mg orally QD venlafaxine extended release (XR) one 75 mg orally QD
Locations(7)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000476336